Frontiers | Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and related peptides in cognition deficits

Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and related peptides in cognition deficits

10k
Total downloads
48k
Total views and downloads

Download PDF Download EPUB

Articles

EDITORIAL

Published on 13 Sep 2021

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits

Lucia Ciranna
Dora Reglodi
Billy K. Chow
David Vaudry

doi 10.3389/fncel.2021.748970

1,224 views
1 citation

MINI REVIEW

Published on 22 Jun 2021

Pituitary Adenylate Cyclase-Activating Polypeptide in Learning and Memory

Marieke R. Gilmartin
Nicole C. Ferrara

doi 10.3389/fncel.2021.663418

4,482 views
11 citations

CORRECTION

Published on 14 May 2021

Corrigendum: VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy

Diana Cunha-Reis
Ana Caulino-Rocha

doi 10.3389/fncel.2021.691978

1,593 views

ORIGINAL RESEARCH

Published on 14 Aug 2020

Physical Activity Protects the Pathological Alterations of Alzheimer’s Disease Kidneys via the Activation of PACAP and BMP Signaling Pathways

Helga Perényi
Vince Szegeczki
Gabriella Horváth
Barbara Hinnah
Andrea Tamás
Zsolt Radák
Dóra Ábrahám
Róza Zákány
Dora Reglodi
Tamás Juhász

doi 10.3389/fncel.2020.00243

2,939 views
6 citations

REVIEW

Published on 17 Jul 2020

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases

Irene Solés-Tarrés
Núria Cabezas-Llobet
David Vaudry
Xavier Xifró

doi 10.3389/fncel.2020.00221

4,539 views
41 citations

MINI REVIEW

Published on 12 Jun 2020

VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy

Diana Cunha-Reis
Ana Caulino-Rocha

doi 10.3389/fncel.2020.00153

9,107 views
35 citations

MINI REVIEW

Published on 30 Apr 2020

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus

Gregory C. Johnson
Rodney Parsons
Victor May
Sayamwong E. Hammack

doi 10.3389/fncel.2020.00111

3,740 views
29 citations

BRIEF RESEARCH REPORT

Published on 14 Jan 2020

VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects

Shlomo Sragovich
Noy Amram
Adva Yeheskel
Illana Gozes

doi 10.3389/fncel.2019.00589

2,679 views
4 citations

MINI REVIEW

Published on 27 Nov 2019

Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Hippocampal Synaptic Transmission and Plasticity: New Therapeutic Suggestions for Fragile X Syndrome

Lucia Ciranna
Lara Costa

doi 10.3389/fncel.2019.00524

5,229 views
22 citations

ORIGINAL RESEARCH

Published on 18 Sep 2019

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease

R. Lee Mosley
Yaman Lu
Katherine E. Olson
Jatin Machhi
Wenhui Yan
Krista L. Namminga
Jenell R. Smith
Scott J. Shandler
Howard E. Gendelman

doi 10.3389/fncel.2019.00421

6,239 views
36 citations

Share on

Frontiers in Cellular Neuroscience

Cellular Neuropathology
Non-Neuronal Cells
Cellular Neurophysiology

Participating Journals

Frontiers in Behavioral Neuroscience
- Learning and Memory
- 2.6 impact factor
- 4.7 citescore

Impact

48kTopic views
36kArticle views
10kArticle downloads

View impact

Submit your idea

Articles

Editorial: Novel Therapeutic Potential for Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), Vasoactive Intestinal Peptide (VIP) and Related Peptides in Cognition Deficits

Pituitary Adenylate Cyclase-Activating Polypeptide in Learning and Memory

Corrigendum: VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy

Physical Activity Protects the Pathological Alterations of Alzheimer’s Disease Kidneys via the Activation of PACAP and BMP Signaling Pathways

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Against Cognitive Decline in Neurodegenerative Diseases

VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Signaling in the Hippocampal Dentate Gyrus

VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects

Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Hippocampal Synaptic Transmission and Plasticity: New Therapeutic Suggestions for Fragile X Syndrome

A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease

Frontiers in Cellular Neuroscience

Participating Journals

Impact